pDelayed‐type hypersensitivity to subcutaneous lidocaine with tolerance to articaine: confirmation by in vivo and in vitro tests
- 1 June 1996
- journal article
- case report
- Published by Wiley in Contact Dermatitis
- Vol. 34 (6) , 387-389
- https://doi.org/10.1111/j.1600-0536.1996.tb02238.x
Abstract
A 43-year-old woman suffered from recurrent localized swellings and an eczematous dermatitis starting 1 day after an injection of lidocaine. Intradermal patch and lymphocyte transformation tests revealed sensitization to lidocaine and cross-reactivity to the other aminoacylamide local anesthetics bupivacaine, mepivacaine and prilocaine, but not to articane. Contact allergy to the ester local anesthetics benzocaine, procaine and tetracaine, the quinoline or aminoacylamide cinchocaine, and the preservatives methylparaben and metabisulfite, was excluded. A subcutaneous challenge with articaine was well tolerated.Keywords
This publication has 10 references indexed in Scilit:
- Contact sensitivity to lignocaineClinical and Experimental Dermatology, 1993
- Type IV allergy to amide‐type local anestheticsContact Dermatitis, 1991
- Contact sensitivity to lignocaine and prilocaineContact Dermatitis, 1990
- Contact Sensitivity to the Amide Anesthetics Lidocaine, Prilocaine, and MepivacaineArchives of Dermatology, 1986
- Dermatitis from lignocaineContact Dermatitis, 1985
- The relationship between in vivo and in vitro reactivity of patients with a history of allergy to local anaestheticsBritish Dental Journal, 1982
- Contact allergy to lidocaineContact Dermatitis, 1979
- Diagnosis of drug allergy in vitro with the lymphocyte transformation testJournal of Allergy, 1967